STOCK TITAN

GENFIT (GNFT) furnishes half-year 2025 business and financial report via Form 6-K

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

GENFIT S.A. furnished a Form 6-K as a foreign private issuer to provide its Half-Year Business and Financial Report for the period ended June 30, 2025, attached as Exhibit 99.1. The report itself contains the detailed business and financial information.

The company also states that this Form 6-K, including Exhibit 99.1, is incorporated by reference into its existing registration statements on Form F-3 and Form S-8 and their related prospectuses from the filing date, unless later filings supersede it.

Positive

  • None.

Negative

  • None.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Date of report: September 22, 2025
Commission File Number: 001-38844
GENFIT S.A.
(Translation of registrant’s name into English)

Parc Eurasanté
885, avenue Eugène Avinée
59120 Loos, France

(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F      Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):








INCORPORATION BY REFERENCE


The contents of this report on Form 6-K (including Exhibit 99.1) are hereby incorporated by reference into the registrant’s registration statement on Form F-3 (File No. 333-271312) and registration statement on Form S-8 (File No. 333-271311) and related prospectuses, as such registration statements and prospectuses may be amended from time to time, and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. Information contained on, or that can be accessed through, any website included in Exhibit 99.1 is expressly not incorporated by reference.




EXHIBIT LIST
ExhibitDescription
99.1
Half-Year Business and Financial Report for the period ended June 30, 2025




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
GENFIT S.A.
Date: September 22, 2025By:/s/ Pascal PRIGENT
Name: Pascal PRIGENT
Title: Chief Executive Officer


FAQ

What does GENFIT (GNFT) disclose in this Form 6-K?

GENFIT uses this Form 6-K to furnish its Half-Year Business and Financial Report for the period ended June 30, 2025. The detailed operating and financial results are contained in Exhibit 99.1 to the report.

Which period does GENFIT’s half-year report in the 6-K cover?

The half-year business and financial report attached to GENFIT’s Form 6-K covers the period ended June 30, 2025. This document provides interim information between the company’s annual reports.

How is this GENFIT (GNFT) Form 6-K used in its registration statements?

GENFIT states that this Form 6-K, including Exhibit 99.1, is incorporated by reference into its Form F-3 and Form S-8 registration statements and related prospectuses, becoming part of those documents from the filing date.

Who signed GENFIT’s September 22, 2025 Form 6-K filing?

The Form 6-K was signed on behalf of GENFIT S.A. by Pascal PRIGENT, the company’s Chief Executive Officer, dated September 22, 2025, indicating executive authorization of the furnished information.

Does GENFIT’s Form 6-K include website information by reference?

GENFIT explicitly states that any information contained on, or accessible through, websites included in Exhibit 99.1 is not incorporated by reference. Only the Form 6-K and Exhibit 99.1 themselves are incorporated.
Genfit S.A.

NASDAQ:GNFT

View GNFT Stock Overview

GNFT Rankings

GNFT Latest News

GNFT Latest SEC Filings

GNFT Stock Data

242.51M
50.00M
Biotechnology
Healthcare
Link
France
Loos